EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016

Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Task…, Kanshi Minamitani, Hirokazu Sato, Hidemi Ohye, Shohei Harada, Osamu Arisaka

Clinical Pediatric Endocrinology · 2017 · 26 (2) · 29-62

DOI: 10.1297/cpe.26.29 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Pediatric Endocrinology, 2017. Verfasst von Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Task… und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Teikyo University Chiba Medical Center, Chiba, Japan. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Graves’ diseaseguidelinestreatment

Autor:innen und Institutionen

  • Department of Pediatrics, Teikyo University Chiba Medical Center, Chiba, Japan.
  • Sunrise Children's Clinic, Chiba, Japan.
  • Department of Internal Medicine, Ito Hospital, Tokyo, Japan.
  • Division of Neonatal Screening, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan.

Zitieren

APA

Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Task…, Minamitani, K., Sato, H., Ohye, H., Harada, S., & Arisaka, O. (2017). Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016. Clinical Pediatric Endocrinology, 26(2), 29-62. https://doi.org/10.1297/cpe.26.29

Vancouver

Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Task…, Minamitani K, Sato H, Ohye H, Harada S, Arisaka O. Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016. Clinical Pediatric Endocrinology. 2017;26(2):29-62. doi:10.1297/cpe.26.29

BibTeX
@article{CommitteeonPharmaceuticalAffairsJapaneseSocietyforPediatricEndocrinologyandthePediatricThyroidDiseaseCommitteeJapanThyroidAssociationTask2017,
  author = {Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Task…, Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Task… and Minamitani, Kanshi and Sato, Hirokazu and Ohye, Hidemi and Harada, Shohei and Arisaka, Osamu},
  title = {Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016},
  journal = {Clinical Pediatric Endocrinology},
  year = {2017},
  volume = {26},
  number = {2},
  pages = {29--62},
  doi = {10.1297/cpe.26.29}
}
Kostenlos starten →